CDKN2A and ovarian cancer: Intriguingly, Todd and colleagues demonstrated that ectopic overexpression of p16 in p16-positive ovarian cancer cell lines did not result in a cessation of the cell cycle, despite co-expressing RB, suggesting that unidentified downstream pathway defects could be present42.